Press Releases

Vital Support for Zika Response Provided by Pfizer and Pfizer Foundation Contributions

To support efforts to stem the Zika outbreak, the CDC Foundation announced a $1 million donation from the Pfizer Foundation in funding for the comprehensive Zika response. Additionally, in-kind donations of up to 170,000 doses of injectable reversible contraceptive product from Pfizer have been provided for the Zika Contraception Access Network (Z-CAN) in Puerto Rico. In addition to donations of products and funding from multiple partners, this donation will provide essential support against this growing health threat for women who choose to delay or avoid pregnancy.


Comprehensive Zika Prevention Campaign Launches in Puerto Rico

A new communications campaign aimed at empowering pregnant women on how to prevent Zika virus transmission has launched in Puerto Rico. The campaign, part of an effort with the Centers for Disease Control and Prevention (CDC), the CDC Foundation, the Puerto Rico Department of Health and other partners announced in May, also focuses on empowering the social networks surrounding pregnant women—including partners, families, neighbors and community members—to take action to #StopZika in their homes and communities. 


Bayer Donations Help Provide Zika Protection for Women, Including Greater Access to Contraceptive Options and Improved Mosquito Control

In response to the growing Zika virus health threat, Bayer today committed to supporting two critical aspects of the Zika response in Puerto Rico: providing women and their partners who want to delay or avoid pregnancy during the Zika outbreak with improved access to a range of contraceptive methods and giving additional protection to families who want to sleep under mosquito-repelling bed nets. 




CDC Foundation, Pfizer and CDC Partner to Develop Longitudinal Data Collection System for Sickle Cell Disease

The CDC Foundation is partnering with the U.S. Centers for Disease Control and Prevention’s (CDC) Division of Blood Disorders within the National Center on Birth Defects and Developmental Disabilities, the California Rare Disease Surveillance Program (a project of the Public Health Institute, located in Oakland, CA) and Pfizer Inc. to support the development and implementation of a longitudinal data collection system for Americans with sickle cell disease.